Histologic findings in normal breast tissues: Comparison to reduction mammaplasty and benign breast disease tissues

Breast Cancer Research and Treatment

Volumn 133, Issue 1, 2012, Pages 169-177

  Degnim, Amy C ^a   Visscher, Daniel W ^a   Hoskin, Tanya L ^a   Frost, Marlene H ^a   Vierkant, Robert A ^a   Vachon, Celine M ^a   Shane Pankratz, V ^a   Radisky, Derek C ^b   Hartmann, Lynn C ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Benign breast disease; Normal breast tissue; Reduction mammoplasty

Indexed keywords

ADULT; AGED; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST HYPERPLASIA; BREAST REDUCTION; CANCER RISK; CONTROLLED STUDY; DONOR; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INVOLUTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TISSUE SECTION; TUMOR GROWTH; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; CASE-CONTROL STUDIES; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMAPLASTY; MAMMARY GLANDS, HUMAN; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; YOUNG ADULT;

EID: 84860345328     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1746-1     Document Type: Review

References (24)

1. L Jin A Fuchs SJ Schnitt, et al. 1997 Expression of scatter factor and c-met receptor in benign and malignant breast tissue Cancer 79 749 760 9024713 10.1002/(SICI)1097-0142(19970215)79:4<749::AID-CNCR12>3.0.CO;2-# 1:CAS:528:DyaK2sXhsFCmsro%3D (Pubitemid 27076341)
2. JR Bernardes Jr S Nonogaki MT Seixas, et al. 1999 Effect of a half dose of tamoxifen on proliferative activity in normal breast tissue Int J Gynaecol Obstet 67 33 38 10576237 10.1016/S0020-7292(99)00092-2 1:CAS:528: DyaK1MXmvFWgtbk%3D (Pubitemid 29495979)
3. XJ Ma R Salunga JT Tuggle, et al. 2003 Gene expression profiles of human breast cancer progression Proc Natl Acad Sci USA 100 5974 5979 12714683 10.1073/pnas.0931261100 1:CAS:528:DC%2BD3sXjvFOlt78%3D (Pubitemid 36576916)
4. IM Ciris KK Bozkurt S Baspinar FN Kapucuoglu 2011 Immunohistochemical COX-2 overexpression correlates with HER-2/neu overexpression in invasive breast carcinomas: a pilot study Pathol Res Pract 207 182 187 21371829 10.1016/j.prp.2011.01.005 1:CAS:528:DC%2BC3MXjtFWmtr4%3D
5. KJ Dedes R Natrajan MB Lambros, et al. 2011 Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer Eur J Cancer 47 138 150 20832293 10.1016/j.ejca.2010.08.007 1:CAS:528:DC%2BC3cXhsFyltLbP
6. LC Hartmann TA Sellers MH Frost, et al. 2005 Benign breast disease and the risk of breast cancer N Engl J Med 353 229 237 16034008 10.1056/NEJMoa044383 1:CAS:528:DC%2BD2MXmt1KmsrY%3D (Pubitemid 41058322)
7. AC Degnim DW Visscher HK Berman, et al. 2007 Stratification of breast cancer risk in women with atypia: a Mayo cohort study J Clin Oncol 25 2671 2677 17563394 10.1200/JCO.2006.09.0217 (Pubitemid 47123172)
8. KP McKian CA Reynolds DW Visscher, et al. 2009 Novel breast tissue feature strongly associated with risk of breast cancer J Clin Oncol 27 5893 5898 19805686 10.1200/JCO.2008.21.5079
9. DW Visscher VS Pankratz M Santisteban, et al. 2008 Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer J Natl Cancer Inst 100 421 427 18334709 10.1093/jnci/djn036 1:CAS:528: DC%2BD1cXjs1GqtLw%3D (Pubitemid 351480513)
10. M Santisteban C Reynolds EG Barr Fritcher, et al. 2010 Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia Breast Cancer Res Treat 121 431 437 19774459 10.1007/s10549-009-0534-7 1:CAS:528:DC%2BC3cXmtlyhsro%3D
11. MP Madigan RG Ziegler J Benichou C Byrne RN Hoover 1995 Proportion of breast cancer cases in the United States explained by well-established risk factors J Natl Cancer Inst 87 1681 1685 7473816 10.1093/jnci/87.22.1681 1:STN:280:DyaK28%2Flt1elsg%3D%3D
12. Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center. https://komentissuebank.iu.edu/. Accessed 23 Aug 2011
13. WD Dupont DL Page 1985 Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 146 151 3965932 10.1056/NEJM198501173120303 1:STN:280:DyaL2M%2Fos1Wguw%3D%3D (Pubitemid 15192861)
14. CL Carter DK Corle MS Micozzi A Schatzkin PR Taylor 1988 A prospective study of the development of breast cancer in 16,692 women with benign breast disease Am J Epidemiol 128 467 477 3414655 1:STN:280:DyaL1czisVektA%3D%3D
15. SJ London JL Connolly SJ Schnitt GA Colditz 1992 A prospective study of benign breast disease and the risk of breast cancer JAMA 267 941 944 1734106 10.1001/jama.1992.03480070057030 1:STN:280:DyaK387jtVegsQ%3D%3D
16. TR Milanese LC Hartmann TA Sellers, et al. 2006 Age-related lobular involution and risk of breast cancer J Natl Cancer Inst 98 1600 1607 17105983 10.1093/jnci/djj439 (Pubitemid 44811643)
17. I Pitanguy E Torres F Salgado GA Pires Viana 2005 Breast pathology and reduction mammaplasty Plast Reconstr Surg 115 729 734 15731670 10.1097/01.PRS.0000152683.62899.50 1:CAS:528:DC%2BD2sXkt1GgsA%3D%3D discussion 735 (Pubitemid 40316412)
18. JD Boice Jr I Persson LA Brinton, et al. 2000 Breast cancer following breast reduction surgery in Sweden Plast Reconstr Surg 106 755 762 11007385 10.1097/00006534-200009040-00001
19. MH Brown M Weinberg N Chong R Levine E Holowaty 1999 A cohort study of breast cancer risk in breast reduction patients Plast Reconstr Surg 103 1674 1681 10323701 10.1097/00006534-199905060-00015 1:STN:280:DyaK1M3lsFejsw%3D%3D (Pubitemid 29206870)
20. MH Gail LA Brinton DP Byar, et al. 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879 1886 2593165 10.1093/jnci/81.24. 1879 1:STN:280:DyaK3c%2FnvF2kuw%3D%3D (Pubitemid 20026073)
21. PP Rosen R Senie D Schottenfeld R Ashikari 1979 Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment Ann Surg 189 377 382 218506 10.1097/00000658-197903000-00021 1:STN:280: DyaE1M7ktlyktA%3D%3D (Pubitemid 9137913)
22. PJ Chuba MR Hamre J Yap, et al. 2005 Bilateral risk for subsequent breast cancer after lobular carcinoma-in situ: analysis of surveillance, epidemiology, and end results data J Clin Oncol 23 5534 5541 16110014 10.1200/JCO.2005.04.038
23. CJ Fabian BF Kimler CM Zalles, et al. 2000 Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model J Natl Cancer Inst 92 1217 1227 10922407 10.1093/jnci/92.15.1217 1:STN:280:DC%2BD3cvhsVWrtA%3D%3D (Pubitemid 30627730)
24. RA Vierkant LC Hartmann VS Pankratz, et al. 2009 Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat 117 193 196 18592369 10.1007/s10549-008-0082-6